Cognetivity Neurosciences Ltd. Stock
Stocks
CGNSF
CA19243C1005
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
20:19:29 25/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | - |
| Market Cap | 1.2M 857K 746K 706K 642K 82.04M 1.2M 8.41M 3.25M 41.69M 3.22M 3.15M 133M | P/E 2022 |
-2.9x | P/E 2023 | -2.8x |
|---|---|---|---|---|---|
| Enterprise Value | 245K 175K 153K 144K 131K 16.78M 246K 1.72M 665K 8.53M 658K 644K 27.3M | EV / Sales 2022 |
-
| EV / Sales 2023 | 437,922,999x |
| Free-Float |
85.56% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -99.00% |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.14 |
| 5 years | 0 | | 0.7 |
| 10 years | 0 | | 1.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 01/04/2013 |
Mark Phillips
CMP | Compliance Officer | 67 | 21/12/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 01/01/2017 |
Mark Phillips
BRD | Director/Board Member | 67 | 21/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/04/24 | Option | Founder | 600,000 | 0.6697% | ||
| 15/04/24 | Option | Founder | 600,000 | 0.6697% | ||
| 23/06/23 | Sell | Founder | 1,108,160 | 1.3030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.00% | -.--% | - | - | 93 | |
| -0.43% | +1.06% | -3.94% | +26.69% | 42.89B | |
| +2.37% | +1.63% | -43.77% | +130.73% | 12.32B | |
| +2.38% | +5.83% | -3.34% | +95.08% | 5.8B | |
| +2.63% | +8.97% | +56.08% | - | 4.2B | |
| +9.18% | +11.24% | - | - | 2.01B | |
| +0.59% | +1.15% | +4.62% | -39.42% | 1.48B | |
| -0.60% | -3.93% | -39.62% | - | 1.02B | |
| +0.40% | -0.98% | +14.45% | +154.77% | 999M | |
| -3.37% | -4.97% | +32.16% | +44.38% | 908M | |
| Average | -8.50% | -0.12% | +2.08% | +68.70% | 7.16B | |
| Weighted average by Cap. | +1.10% | +1.16% | -6.93% | +53.47% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | 0.05 0.03 0.03 0.03 0.02 3.11 0.05 0.32 0.12 1.58 0.12 0.12 5.05 |
| Net income | -13.13M -9.38M -8.17M -7.73M -7.03M -899M -13.19M -92.12M -35.62M -457M -35.24M -34.46M -1.46B | -7.43M -5.31M -4.63M -4.38M -3.98M -509M -7.47M -52.17M -20.17M -259M -19.96M -19.51M -828M |
| Net Debt | -82.43K -58.91K -51.31K -48.56K -44.12K -5.64M -82.84K -578K -224K -2.87M -221K -216K -9.18M | -953K -681K -594K -562K -510K -65.26M -958K -6.69M -2.59M -33.17M -2.56M -2.5M -106M |
Employees
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CGNSF Stock
Select your edition
All financial news and data tailored to specific country editions
